Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Saturday, December 28, 2013
Advocates Urge Congress to Boost FDA’s Fiscal 2014 Funding
With the FDA set to tackle a host of new responsibilities, Congress should boost the agency’s fiscal 2014 funding to help it carry out its expanded mission, advocates for the FDA say. Read More
Nevada Compounder Green Valley Drugs Warned for Aseptic Practices Following April Recall
December 24, 2013
Nevada-based Green Valley Drugs, which recalled all of its sterile compounded products in April, has been warned by the FDA for a lack of sterility assurance and general quality control. Read More
Indian Hospira Plant Gets Form 483 With 23 Observations
December 27, 2013
The FDA has hit Hospira with a new Form 483 containing 23 observations after a return visit to its Irungattukottai, India, plant. Read More
December 28, 2013 Area attorney applauds fund for meningitis victims BY ANNE STANTON astanton@record-eagle.com
TRAVERSE CITY — A Traverse City attorney who represents dozens of clients who have suffered or died from tainted steroid injections welcomed the announcement of a $100 million-plus fund to compensate victims.
“I am encouraged by how quickly this came out,” said Traverse City attorney Mark Dancer.
continue to read here
Subscribe to:
Posts (Atom)